Filing Details

Accession Number:
0001209191-23-045235
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-09 18:23:31
Reporting Period:
2023-08-08
Accepted Time:
2023-08-09 18:23:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662774 Quince Therapeutics Inc. QNCX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638945 Dirk Thye C/O Cortexyme, Inc.
601 Gateway Blvd, #1250
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-08 80,000 $1.24 360,911 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.